Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
01.12.2024 16:00:00

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

Philips
24.10 CHF -0.60%
Kaufen / Verkaufen


December 1, 2024

  • Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications
  • Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive cases


Amsterdam, the Netherlands and Chicago, USA –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a boost in confidence in clinical decision-support with AI and smart workflow automation capabilities in the company’s recently introduced CT 5300 system, which is making its North America debut at RSNA 2024. Key to this latest innovation is Philips’ CT Smart Workflow featuring a comprehensive suite of AI-enabled ‘Precise’ software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients.


"By equipping the CT 5300 with our unique NanoPanel Precise detector and ultra-low noise Precise Image reconstruction technology, together with our latest AI-driven CT Smart Workflow solutions, we are integrating hardware, software, and AI to make high-quality care more productive, cost-effective, and widely accessible,” said Dan Xu, CT Business Leader at Philips. "The productivity and diagnostic confidence enhancements that AI can deliver to CT imaging empower care teams and ease departmental workflow, helping to mitigate today’s chronic shortage of highly skilled radiologists and technicians.”


End-to-end AI-driven smart workflow
Philips CT Smart Workflow solutions include camera-based Precise Position, which improves the accuracy of vertical positioning relative to manual positioning by up to 50% during scan preparation, increases user-to-user consistency by up to 70%, and reduces positioning time by up to 23% [1]. Also included is Precise Cardiac, which compensates for cardiac motion to improve visualization of the coronary arteries during CT imaging, even in patients with a rapid heartbeat, and Precise Brain, which automatically reformats scans to help improve visualization for fast confident diagnosis of the respective anatomies. In addition, Precise Image delivers fast, high-quality image reconstruction with an 80% lower radiation dose, 85% lower noise, and 60% improved low-contrast detectability [2], making the CT 5300 ideal for sites developing cardiac programs and ultra-low dose screening.


CT 5300 is seamlessly integrated with Advanced Visualization Workspace, Philips’ comprehensive, scalable AI-enabled image post-processing platform [3,4]. This platform is designed to streamline radiology workflows to help deliver high-quality care, enhance diagnostic confidence, and speed image reading and reporting. The unique clinical depth and deployment capabilities of Advanced Visualization Workspace allow it to scale to meet changing clinical needs and future expansion.


Collaboration with Annalise.ai for triage evaluation in emergency departments
Philips also announced a pilot with medical imaging AI solutions company Annalise.ai to investigate the feasibility of Annalise Critical Care AI – a comprehensive critical case triage support solution – to enhance triage support and optimize workflows for conditions like traumatic brain injury (TBI), which require time-critical intervention. This newly announced collaboration aims to evaluate ways to further streamline workflows and prioritize time-sensitive cases. The collaboration will investigate integrating Annalise Critical Care AI – the most comprehensive AI-driven triage product for chest X-ray and non-contrast CT of the brain available in the USA. By flagging and prioritizing 12 time-sensitive clinical findings often encountered in emergency departments, these AI capabilities help clinicians focus on the most critical cases. This is particularly valuable during nights and weekends when fewer staff are on duty, and delays in intervention pose a significant risk to patients.


"This is an exciting time for radiology. Our solutions are designed to streamline workflows and boost productivity for radiology teams. Together with Philips, we look forward to making high-quality care truly accessible,” said Dimitry Tran, co-founder and deputy CEO of Annalise.ai.


Critical Care AI has been shown to improve median report turnaround times by up to 39% [5]. It is the first computer-aided detection triage device to receive FDA Breakthrough Device Designation and secure NTAP (New Technology Add-on Payment) for obstructive hydrocephalus (water on the brain) detection. Philips will also be evaluating the Annalise Enterprise CTB solution – a comprehensive clinical decision-support solution that can detect up to 130 radiology findings – for sites outside of the USA.


The Philips CT 5300 with Advanced Visualization Workspace will be showcased at the Philips Booth #6730 at #RSNA24. Visit Philips at RSNA for more information.



[1] Based on an internal Philips assessment conducted by five clinical experts, comparing manual positioning versus Precise Position in 40 clinical cases using a human body phantom.
[2] In clinical practice, the use of Precise Image may reduce CT patient dose depending on the clinical task, patient size, and anatomical location. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Dose reduction assessments were performed using reference body protocols with 1.0 mm slices at the "Smoother” setting of Precise Image, and tested on the MITA CT IQ Phantom (CCT189, The Phantom Laboratory) assessing the 10 mm pin and compared to filtered-back projection. A range is seen across the four pins, using a channelized hoteling observer tool, that includes lower image noise by 85% and improved low-contrast detectability from 0% to 60% at 50% to 80% dose reduction. NPS curve shift is used to evaluate image appearance, as measured on a 20 cm water phantom in the center 50mm x 50 mm region of interest, with an average shift of 6% or less.
[3] Specktor B. Preprocessing prediction of advanced algorithms for medical imaging, J Digit Imaging 31:42-50, 2018
[4] Applications may not be available in all markets. Please Contact your Philips representative for more details.
[5] S. Karunasena, M. Milne, D. Rosewarne, C. Jones. Radiologist reporting productivity benefits from AI-assisted triage of CXR studies in clinical practice. Poster, British Institute of Radiology Annual Congress 2022. https://annalise.ai/evidence/radiologist-reporting-productivity-benefits-from-ai-assisted-triage-of-cxr-studies-in-clinical-practice/

For further information, please contact:


Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail : kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Analysen zu Philips N.V.

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
29.11.24 Philips Hold Jefferies & Company Inc.
26.11.24 Philips Neutral UBS AG
21.11.24 Philips Overweight Barclays Capital
04.11.24 Philips Buy Goldman Sachs Group Inc.
30.10.24 Philips Hold Deutsche Bank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: Fiserv Inc., Cintas & Blackstone mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Fiserv Inc.
✅ Cintas
✅ Blackstone

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: Fiserv Inc., Cintas & Blackstone mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’200.00 19.53
Short 12’425.70 13.93 UBS07U
Short 12’919.42 8.77 0MSSMU
SMI-Kurs: 11’744.58 29.11.2024 17:30:00
Long 11’208.50 19.03 S5TMYU
Long 10’977.64 13.85 SSRMMU
Long 10’505.70 8.93 5SSMZU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten